Gene · 10643
Papers3,038
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 3,038
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Lines. | Cancers (Basel) | 2022 | 36139627 | PubTator, text mining | PubMed |
| Promising Roles of Circular RNAs as Biomarkers and Targets for Potential Diagnosis and Therapy of Tuberculosis. | Biomolecules | 2022 | 36139074 | PubTator, text mining | PubMed |
| Unveiling the m6A Methylation Regulator Links between Prostate Cancer and Periodontitis by Transcriptomic Analysis. | Dis Markers | 2022 | 36133437 | PubTator, text mining | PubMed |
| STMN1 as a novel prognostic biomarker in HCC correlating with immune infiltrates and methylation. | World J Surg Oncol | 2022 | 36127700 | PubTator, text mining | PubMed |
| New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC. | Front Pharmacol | 2022 | 36120320 | PubTator, text mining | PubMed |
| The role of RNA modification in hepatocellular carcinoma. | Front Pharmacol | 2022 | 36120301 | PubTator, text mining | PubMed |
| Immunotherapy resistance in esophageal cancer: Possible mechanisms and clinical implications. | Front Immunol | 2022 | 36119033 | PubTator, text mining | PubMed |
| Ferroptosis regulators related scoring system by Gaussian finite mixture model to predict prognosis and immunotherapy efficacy in nasopharyngeal carcinoma. | Front Genet | 2022 | 36118882 | PubTator, text mining | PubMed |
| Molecular subtype identification and predictive power of N6-methyladenosine regulator in unexplained recurrent pregnancy loss. | Front Genet | 2022 | 36118846 | PubTator, text mining | PubMed |
| METTL3 dual regulation of the stability of LINC00662 and VEGFA RNAs promotes colorectal cancer angiogenesis. | Discov Oncol | 2022 | 36114893 | PubTator, text mining | PubMed |
| ALS-linked loss of Cyclin-F function affects HSP90. | Life Sci Alliance | 2022 | 36114006 | PubTator, text mining | PubMed |
| Prognostic model based on m6A-associated lncRNAs in esophageal cancer. | Front Endocrinol (Lausanne) | 2022 | 36111294 | PubTator, text mining | PubMed |
| Identification of m6A modification patterns and development of m6A-hypoxia prognostic signature to characterize tumor microenvironment in triple-negative breast cancer. | Front Immunol | 2022 | 36105819 | PubTator, text mining | PubMed |
| MND1 functions as a potential prognostic biomarker associated with cell cycle and immune infiltration in kidney renal clear cell carcinoma. | Aging (Albany NY) | 2022 | 36098680 | PubTator, text mining | PubMed |
| m6A regulator-mediated RNA methylation modification patterns are involved in immune microenvironment regulation of coronary heart disease. | Front Cardiovasc Med | 2022 | 36093132 | PubTator, text mining | PubMed |
| Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer. | Front Immunol | 2022 | 36091006 | PubTator, text mining | PubMed |
| CircSMARCA5: A key circular RNA in various human diseases. | Front Genet | 2022 | 36081987 | PubTator, text mining | PubMed |
| Molecular Testing for Thyroid Nodules: The Experience at McGill University Teaching Hospitals in Canada. | Cancers (Basel) | 2022 | 36077677 | PubTator, text mining | PubMed |
| The Role of RNA-Binding Proteins in Hematological Malignancies. | Int J Mol Sci | 2022 | 36076951 | PubTator, text mining | PubMed |
| Adenoid Ameloblastoma with Dentinoid: A systematic review. | Sultan Qaboos Univ Med J | 2022 | 36072074 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10643/papers?page=54